Literature DB >> 16580894

Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).

Soo-Youn Lee1, Hyeon Ju Oh, Jong Won Kim, Yoon Gyoon Kim, Chul Jin Moon, Eun Hee Lee.   

Abstract

We developed and validated a simple, rapid, and accurate HPLC-MS/MS method with simple protein precipitation for the determination of orphenadrine. Injection-to-injection running time was 3 min with a retention time of orphenadrine of 1.1 min. The linear assay range was 1-200 ng/mL (r2 > 0.99). The intra- and inter-assay imprecisions were CV 0.6-4.2% and CV 1.6-6.1%, respectively. The accuracy, extraction recovery, specificity and stability were satisfactory. Using the measured plasma concentrations of orphenadrine in 24 healthy subjects, pharmacokinetic profiles of orphenadrine were evaluated (AUC(0-72,) 1565+/-731 ng h/mL, Cmax 82.8+/-26.2 ng/mL, Tmax 3.0+/-0.9 h, elimination half-life 25.8+/-10.3 h).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580894     DOI: 10.1016/j.jchromb.2006.02.056

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Development of a capillary electrophoresis method for the determination of orphenadrine citrate in tablets in the presence of paracetamol.

Authors:  Dana N Haj-Ali; Imad I Hamdan
Journal:  Saudi Pharm J       Date:  2010-08-02       Impact factor: 4.330

2.  Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y.

Authors:  Mohamed I Walash; Fathalla F Belal; Manal I Eid; Samah Abo El Abass Mohamed
Journal:  Chem Cent J       Date:  2011-10-08       Impact factor: 4.215

3.  A randomized single-dose, two-period crossover bioequivalence study of two fixed-dose Paracetamol/Orphenadrine combination preparations in healthy volunteers under fasted condition.

Authors:  Kit Yee Cheah; Kar Yee Mah; Lai Hui Pang; Shi Min Ng; Jia Woei Wong; Siew Siew Tan; Hong Zhe Tan; Kah Hay Yuen
Journal:  BMC Pharmacol Toxicol       Date:  2020-06-23       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.